Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users
Condition(s) studied
Investigational drug(s) / intervention(s)
Brief motivational intervention: identification followed by a brief motivational intervention in pharmacies (BMI) based on the mobilisation of patients' psychosocial skills and the integration of tools to help reduce consumption of BZD/Z prescribed over the long term (≥ 6 months).
Study summary
We hypothesise that a short-term intervention by dispensing pharmacists is feasible and relatively easy to implement, and that it could have an impact on the deprescribing of BZD/Z in adult patients.
Two primary objectives will be evaluated in a sequential hierarchical manner, with two primary endpoints analysed one after the other, without alpha risk adjustment, but the second can only be analysed if the null hypothesis is rejected for the first:
1. Evaluate the impact of brief motivational intervention (BMI) on reducing the daily dose of BZD/Z prescribed at 6 months (superiority hypothesis) compared with the usual practice of dispensing BZD/Z in pharmacies.
2. Evaluate the impact of BMI on clinical worsening at 6 months (non-inferiority hypothesis) in comparison with the usual practice of dispensing BZD/Z in pharmacies.
Eligibility
Primary outcome measure(s)
- Change of the Daily dose of BZD/Z drug — 6 months
Change of at least 50% of the Defined Daily Dose (DDD) initially prescribed (reduction), 6 months after the BPMI (during the last 4 weeks prior to the assessment) - Worsening of the clinical symptoms of anxiety and/or sleep disorders — 6 months
Clinical worsening is defined as: * An increase in anxiety ≥ 3 points of the HAD-A sub-score (the minimum clinically significant difference being estimated at 3.2 +/- 4. * and/or an increase ≥ 8 points in the ISI (the minimum difference corresponding to a moderate improvement being estimated at \> 7 points.
Trial sites (20)
| Facility | City | Region | Status |
|---|---|---|---|
| Pharmacie Riffard Annonay | Annonay | France | Recruiting |
| Pharmacie du Village | Auriol | France | Recruiting |
| Pharmacie des Champs Dolent | Beauvais | France | Recruiting |
| Pharmacie Troisgros | Cap-d'Ail | France | Recruiting |
| Pharmacie des Fontanilles | Castelnaudary | France | Recruiting |
| Pharmacie Dolus d'Oléron | Dolus-d'Oléron | France | Recruiting |
| Pharmacie de Dommartin | Dommartin | France | Recruiting |
| Pharmacie du Mont Guillaume | Embrun | France | Recruiting |
| Ma Pharmacie Evenos | Évenos | France | Recruiting |
| Pharmacie du Pog | Lavelanet | France | Recruiting |
| Pharmacie de Lentilly | Lentilly | France | Recruiting |
| Pharmacie Thomas | Ludres | France | Recruiting |
| Pharmacie Saint Pierre Marignane | Marignane | France | Recruiting |
| Pharmacie Milan Saint-Giniez | Marseille | France | Recruiting |
| Pharmacie de la Sèvre | Moncoutant | France | Recruiting |
| Pharmacie de St georges | Saint-Georges-de-Reineins | France | Recruiting |
| Pharmacie du Théâtre | Saint-Omer | France | Recruiting |
| Pharmacie du Château | Saint-Porchaire | France | Recruiting |
| Pharmacie Labarrière | Savigné-l'Évêque | France | Recruiting |
| Pharmacie de l'Ermitage | Villemoisson-sur-Orge | France | Recruiting |
More University Hospital, Grenoble trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06446349 on ClinicalTrials.gov ↗ ← All trials in France